Are you responsible for administering chemotherapy and biotherapy agents and want to learn more about newly-approved agents? Explore two new classes of cancer treatment agents as well as more in-depth information about blinatumomab.
Sponsored by the Chemotherapy and Biotherapy Special Interest Group
*This continuing nursing education activity was approved by the Oncology Nursing Society, an accredited approver by the American Nurses Credentialing Center’s COA.
